CLINICAL TRIALS PROFILE FOR ATIVAN
✉ Email this page to a colleague
All Clinical Trials for ATIVAN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000441 ↗ | Drug Therapy for Alcohol Detoxification | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 4 | 1969-12-31 | This project will provide relevant clinical information for primary care practitioners treating alcohol withdrawal syndrome in outpatient settings. This double-blind, placebo- controlled clinical trial will compare the effectiveness of lorazepam (Ativan) and carbamazepine (Tegretol) in alcoholics who meet the criteria for a diagnosis of uncomplicated alcohol withdrawal syndrome. Participants are randomized to five days of treatment with a 1-week posttreatment followup. |
| NCT00011297 ↗ | Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 2 | 1969-12-31 | This study will evaluate a safe and useful medication for outpatient detoxification that is as effective as benzodiazepines in the short-term, and more effective in the protracted withdrawal period. Gabapentin (Neurontin) will be compared to a standard benzodiazepine, lorazepam (Ativan), for its effectiveness in treating alcohol withdrawal. |
| NCT00109395 ↗ | Lorazepam Sedation for Critically Ill Children | Completed | Case Western Reserve University | Phase 2/Phase 3 | 2004-09-01 | This clinical trial is being performed under the Best Pharmaceuticals for Children Act, signed into law in 2002 in order to improve pediatric labeling for off-patent drugs. The purpose of this study is to make sure that lorazepam, when given to children who are very sick in the Intensive Care Unit and who are on a breathing machine, is safe and works as well as a drug called midazolam. Midazolam is already approved by the FDA for this use, but lorazepam is not, even though both drugs are commonly used for sedation. |
| NCT00109395 ↗ | Lorazepam Sedation for Critically Ill Children | Completed | The Emmes Company, LLC | Phase 2/Phase 3 | 2004-09-01 | This clinical trial is being performed under the Best Pharmaceuticals for Children Act, signed into law in 2002 in order to improve pediatric labeling for off-patent drugs. The purpose of this study is to make sure that lorazepam, when given to children who are very sick in the Intensive Care Unit and who are on a breathing machine, is safe and works as well as a drug called midazolam. Midazolam is already approved by the FDA for this use, but lorazepam is not, even though both drugs are commonly used for sedation. |
| NCT00109395 ↗ | Lorazepam Sedation for Critically Ill Children | Completed | The EMMES Corporation | Phase 2/Phase 3 | 2004-09-01 | This clinical trial is being performed under the Best Pharmaceuticals for Children Act, signed into law in 2002 in order to improve pediatric labeling for off-patent drugs. The purpose of this study is to make sure that lorazepam, when given to children who are very sick in the Intensive Care Unit and who are on a breathing machine, is safe and works as well as a drug called midazolam. Midazolam is already approved by the FDA for this use, but lorazepam is not, even though both drugs are commonly used for sedation. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ATIVAN
Condition Name
Clinical Trial Locations for ATIVAN
Trials by Country
Clinical Trial Progress for ATIVAN
Clinical Trial Phase
Clinical Trial Sponsors for ATIVAN
Sponsor Name
